Gerresheimer, DE000A0LD6E6

Gerresheimer stock gains 3.20 percent after Centor sale

Published on 10/05/2026 at 21:35 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Gerresheimer stock was last at EUR 28.40 on October 5, 2026, after the Centor disposal closed on October 1. Q2 adjusted EBITDA rose 52.2 percent quarter over quarter.

Isometrische Grafik der Wertschöpfungskette der Pharmaglasherstellung
Gerresheimer AG, ISIN DE000A0LD6E6, veranschaulicht in isometrischer Grafik die gesamte Wertschöpfungskette der Pharmaglasherstellung übersichtlich, Illustration mit AI erstellt.

Gerresheimer stock (ISIN DE000A0LD6E6) was last at EUR 28.40 on Xetra on October 5, 2026, up 3.20 percent from the prior close of EUR 27.52. The move follows the completion of the Centor sale on October 1, a portfolio step that directs proceeds toward debt reduction, according to Gerresheimer.

Centor disposal changes the balance sheet

The completed transaction transfers Gerresheimer's US closures subsidiary Centor to funds advised by Apax Partners. The remaining Primary Packaging Plastics disposal is targeted for the first half of 2027, followed by group refinancing, Packaging News Daily reported on October 1, 2026.

That transaction matters because net financial debt stood above EUR 2 billion in the second quarter. The sale therefore addresses leverage directly, while the second disposal keeps execution risk on the agenda for the next phase.

Q2 EBITDA rebounds from EUR 67 million

Gerresheimer's adjusted EBITDA reached EUR 102 million in Q2 2026, up 52.2 percent from EUR 67 million in Q1 2026. Revenue rose 10.5 percent sequentially to EUR 578 million, but remained 5.9 percent below the EUR 614 million reported for Q2 2025, according to Investing.com on September 30, 2026.

The margin was 17.6 percent in the quarter, while free cash flow before mergers and acquisitions was negative EUR 92 million. The contrast is clear: operating performance improved sharply against Q1, but cash conversion and debt reduction remain central to the investment case.

Analysts keep a cautious rating

Three analysts rate Gerresheimer Hold, with an average price target of EUR 25.60. That target lies 9.9 percent below the EUR 28.40 Xetra price, according to finanzen.ch on September 30, 2026. Jefferies maintained Hold with a EUR 26.80 target on September 30, 2026, as reported by ARIVA.DE.

Stock rises toward the yearly high

Gerresheimer's Xetra price was last at EUR 28.40 at 5:35 p.m. CEST on October 5, 2026. The share remains EUR 9.92 below its 52-week high of EUR 38.32 and EUR 13.57 above its 52-week low of EUR 14.83.

Gerresheimer stock facts

  • Company: Gerresheimer AG
  • ISIN: DE000A0LD6E6
  • WKN: A0LD6E
  • Ticker: GXI
  • Trading venue: Xetra
  • Price (as of October 5, 2026, 5:35 p.m. CEST): EUR 28.40
  • Market capitalization: EUR 980.9 million (as of October 5, 2026)
  • 52-week range: EUR 14.83-38.32 (as of October 5, 2026)
  • Sector / Industry: Healthcare / Medical Instruments and Supplies

Upcoming dates for Gerresheimer stock

  • October 31, 2026: Q3 2026 results

More news and analyses on Gerresheimer stock

Disclaimer...

en | DE000A0LD6E6 | GERRESHEIMER | boerse | 70236781 | bgmi